http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20130142477-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_95363fc2cf0b49e7a4aef32d7cb692a1
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C201-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C205-41
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01J23-755
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B01J23-755
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C205-05
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C201-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C201-06
filingDate 2012-06-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7f5dc1dbd628bc1fbc9f71b06f2b33dc
publicationDate 2013-12-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber KR-20130142477-A
titleOfInvention Method for preparing chiral nitrocyclopropane derivative
abstract Chiral nitrocyclopropane derivatives having physiological activity are disclosed. The present invention is characterized by reacting a nitroalkene derivative with a bromomalonate derivative in the presence of a chiral nickel catalyst, followed by addition of a base to obtain a derivative having high optical purity and yield.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11528906-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11357230-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10294202-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10582709-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10405547-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11180453-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11787765-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11019818-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10227286-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11178873-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9944602-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10442807-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10875838-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11498899-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10654804-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11560367-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11634421-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11589583-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10906873-B2
priorityDate 2012-06-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454092148
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6327
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394811
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426105809
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421057919
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12917014
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID935
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3024
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19917393
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411363308
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412550040
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11198
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419517752
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19917401
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID413371631

Total number of triples: 50.